Indication
Chronic lymphoid leukemia
Chronic lymphoid leukemia, more commonly termed chronic lymphocytic leukemia (CLL), is an indolent hematologic malignancy of the lymphatic and circulatory systems characterized by the clonal proliferation and progressive accumulation of mature-appearing but immunologically dysfunctional B lymphocytes. Read more about Chronic lymphoid leukemia
105 drugs 88 manufacturers
Drugs that treat it
Common Chronic lymphoid leukemia therapies.
DELTASONE (prednisone)
BENDEKA (bendamustine HCl)
PREDNISONE
CYCLOPHOSPHAMIDE
PREDNISONE
PREDNISONE
PREDNISONE INTENSOL (prednisone)
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic lymphoid leukemia, more commonly termed chronic lymphocytic leukemia (CLL), is an indolent hematologic malignancy of the lymphatic and circulatory systems characterized by the clonal proliferation and progressive accumulation of mature-appearing but immunologically dysfunctional B lymphocytes.
Primarily affecting older adults, the abnormal cells infiltrate the bone marrow, peripheral blood, spleen, and lymph nodes.
Key clinical and pathophysiologic features include sustained monoclonal B-cell lymphocytosis, generalized lymphadenopathy, splenomegaly, and progressive bone marrow failure leading to anemia, thrombocytopenia, and increased susceptibility to infections.
- nih.gov
Chronic lymphoid leukemia, more commonly termed chronic lymphocytic leukemia (CLL), is an indolent hematologic malignancy of the lymphatic and circulatory systems characterized by the clonal proliferation and progressive accumulation of mature-appearing but immunologically dysfunctional B lymphocytes Primarily affecting older adults, the abnormal cells infiltrate the bone marrow, peripheral blood, spleen, and lymph nodes Key clinical and pathophysiologic features include sustained monoclonal B-c...
- nih.gov
Chronic lymphoid leukemia, more commonly termed chronic lymphocytic leukemia (CLL), is an indolent hematologic malignancy of the lymphatic and circulatory systems characterized by the clonal proliferation and progressive accumulation of mature-appearing but immunologically dysfunctional B lymphocytes
- nih.gov
Primarily affecting older adults, the abnormal cells infiltrate the bone marrow, peripheral blood, spleen, and lymph nodes
- cancer.gov
Key clinical and pathophysiologic features include sustained monoclonal B-cell lymphocytosis, generalized lymphadenopathy, splenomegaly, and progressive bone marrow failure leading to anemia, thrombocytopenia, and increased susceptibility to infections
- ucsfhealth.org
Key clinical and pathophysiologic features include sustained monoclonal B-cell lymphocytosis, generalized lymphadenopathy, splenomegaly, and progressive bone marrow failure leading to anemia, thrombocytopenia, and increased susceptibility to infections
Personalize your experience
Follow Chronic lymphoid leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.